QA: IASO Biomed Inc in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001662907_2019_IASO_Biomed_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Q Biomed Inc', 'shared_tokens': {'biomed'}}]}
warning Missing logo subcommand.report {}
info NetIncome node detected by revenue/expenses heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'OperatingIncomeLoss'}

Graph

Absolute values for 0001662907, IASO Biomed Inc

  xvar xval
0 AssetsCurrent 141,685
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 744,204
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,325,637
9 ResearchAndDevelopmentExpense 95,000
10 remainder_Expenses 213,000
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 141,685
1 Liabilities 744,204
2 Expenses 1,633,637
3 Revenues 0
4 StockholdersEquity -602,519
5 NetIncome -1,633,637
6 ComprehensiveNetIncome -1,633,637
7 BaseVar 1,259,763
8 EconomicCapitalRatiobeforeLimitedLiability -6.65
9 EconomicCapitalRatio 0.0409

Edgar->Model Mapping

Feature Distribution